BioCentury | Jun 16, 2017
Emerging Company Profile

Metabolic regulation

...Corporate partners: None Number of employees: 6 Funds raised: $11 million Investors: Intervest, SL Investment, NHN Investment...
BioCentury | Mar 9, 2017
Financial News

ImmunoMet Therapeutics completes venture financing

...Texas) raised $5 million in a series B round. New investors Intervest, SL Investment and NHN Investment...
Items per page:
1 - 2 of 2
BioCentury | Jun 16, 2017
Emerging Company Profile

Metabolic regulation

...Corporate partners: None Number of employees: 6 Funds raised: $11 million Investors: Intervest, SL Investment, NHN Investment...
BioCentury | Mar 9, 2017
Financial News

ImmunoMet Therapeutics completes venture financing

...Texas) raised $5 million in a series B round. New investors Intervest, SL Investment and NHN Investment...
Items per page:
1 - 2 of 2